[Surgical therapy of bronchial cancer].
Over the last decades the medical and social importance of bronchial carcinoma has increased because of its incidence and poor prognosis. Until recently only surgery has offered the chance of a cure for non-small-cell lung cancer with a 5-year-survival of 25%. Today with the development of tissue-sparing techniques curative treatment is accessible also to patients with limited lung function and centrally located tumors.
Vogt-Moykopf
I
I
Thorax-Klinik der LVA Baden, Heidelberg-Rohrbach.
Bülzebruck
H
H
Probst
G
G
Merkle
N
N
D000328:Adult; D000368:Aged; D002283:Carcinoma, Bronchogenic / Q000473:pathology / Q000601:surgery*; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000601:surgery*; D018288:Carcinoma, Small Cell / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods; D011183:Postoperative Complications / Q000401:mortality*; D011379:Prognosis
Chirurgische Therapie des Bronchialkarzinoms.